Naoki Manda
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
-
- Cardiovascular Health and Disease Prevention
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Diabetes Treatment and Management 13
- Diabetes Management and Research 4
-
- Metabolism, Diabetes, and Cancer 5
- Peroxisome Proliferator-Activated Receptors 2
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
- Co-authors
- Shin Aoki (15 shared papers)Tatsuya Atsumi (13 shared papers)Yoshio Kurihara (14 shared papers)Hideaki Miyoshi (12 shared papers)Hiroshi Nomoto (11 shared papers)Akinobu Nakamura (11 shared papers)Tomoo Furumoto (3 shared papers)Kyu Yong Cho (8 shared papers)
- Journals
- Journal of Diabetes Investigation (4 papers)Diabetes Obesity and Metabolism (2 papers)PLoS ONE (2 papers)Pharmaceutics (1 paper)Diabetes & Metabolism Journal (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Naoki Manda
23 papers receiving 260 citations
Peers
Comparison fields: 5 of 43
- Endocrinology, Diabetes and Metabolism 173
- Cardiology and Cardiovascular Medicine 36
- Nephrology 10
- Clinical Biochemistry 9
- Pharmacology 15
Countries citing papers authored by Naoki Manda
This map shows the geographic impact of Naoki Manda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Manda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Manda more than expected).
Fields of papers citing papers by Naoki Manda
This network shows the impact of papers produced by Naoki Manda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Manda. The network helps show where Naoki Manda may publish in the future.
Co-authors
The 25 scholars most cited alongside Naoki Manda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 46 | |
| 2 | 2016 | 38 | |
| 3 | 2018 | 29 | |
| 4 | 2017 | 27 | |
| 5 | 2018 | 15 | |
| 6 | 2018 | 14 | |
| 7 | 2009 | 14 | |
| 8 | 2019 | 13 | |
| 9 | 2019 | 11 | |
| 10 | 2017 | 10 | |
| 11 | 2017 | 9 | |
| 12 | 2017 | 8 | |
| 13 | 2018 | 7 | |
| 14 | 2022 | 6 | |
| 15 | 1986 | 6 | |
| 16 | 2021 | 5 | |
| 17 | 2023 | 3 | |
| 18 | Diabetes Mellitus During the Course of Infectious Mononucleosis | 1982 | 2 |
| 19 | 2023 | 2 | |
| 20 | 2017 | 2 |
About Naoki Manda
Naoki Manda is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine and Nephrology, having authored 23 papers that have together received 270 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (13 papers), Metabolism, Diabetes, and Cancer (5 papers), Diabetes Management and Research (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Pancreatic function and diabetes (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Advanced Glycation End Products research (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (173 citations), Cardiology and Cardiovascular Medicine (36 citations), Nephrology (10 citations), Clinical Biochemistry (9 citations) and Pharmacology (15 citations). Naoki Manda has collaborated with scholars based in Japan and United States. Frequent co-authors include Shin Aoki, Tatsuya Atsumi, Yoshio Kurihara, Hideaki Miyoshi, Hiroshi Nomoto, Akinobu Nakamura, Tomoo Furumoto, Kyu Yong Cho, Koji Oba and Hiroyuki Tsutsui. Their work appears in journals such as Journal of Diabetes Investigation, Diabetes Obesity and Metabolism, PLoS ONE, Pharmaceutics and Diabetes & Metabolism Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.